-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics Completes Type C Meeting With FDA To Review Strategy For Advancing (Z)-Endoxifen

Benzinga·12/04/2025 13:07:23
语音播报

Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settings